Compare Palo Alto Networks Inc (PANW) vs Sana Biotechnology Inc (SANA) Price & Performance

Palo Alto Networks IncTrade

Sana Biotechnology IncTrade

Price performance (Past 24H)

Key statistics

Palo Alto Networks Inc vs Sana Biotechnology Inc — how do they compare? Palo Alto Networks Inc trades at $335.38 (market cap $278.85B), while Sana Biotechnology Inc trades at $3.13 (market cap $879.40M). The key difference: Palo Alto Networks Inc is far larger — about 317.1× Sana Biotechnology Inc's market cap, and Palo Alto Networks Inc is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.

	PANW	SANA
Market Cap	$278.85B	$879.40M
Sector	Technology	Health
52-Week High	$358.68	$5.92
52-Week Low	$141.67	$2.68
Enterprise Value	$277.81B	$853.59M

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Palo Alto Networks Inc

No Aura AI signal available yet.

Sana Biotechnology Inc

SANA Biotechnology trades at $3.14, down 0.32% with a bearish technical signal. The company shows negative profitability metrics with ROE at -147.41% and net income of -$244.17M for 2025, though cash burn is projected to improve significantly in 2026. Recent positive developments include NEJM publication of groundbreaking diabetes data and multiple conference presentations highlighting clinical progress.

While analyst sentiment remains strongly bullish (82% buy ratings), the stock faces fundamental challenges with significant losses and high P/B ratio of 7.33. Investment opportunity lies in clinical pipeline advancements, but risks include ongoing cash burn and execution challenges in bringing therapies to market.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

PANW

Palo Alto Networks to acquire Embrace, adding Real User Monitoring and Synthetics to boost app performance insights.PRNewsWire · 1 day agoBullish Argus Research raises Palo Alto Networks price target to $425 on booming AI-driven cybersecurity demand.Danny Green · 1 day agoBullish Cybersecurity ETFs soar as investors shift from semiconductors amid rising cyber threats and AI risks.ETF Trends · 1 day agoBullish View details →

SANA

View details →

About Palo Alto Networks Inc

Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.

About Sana Biotechnology Inc

Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.